Actigall and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actigall (ursodiol) and Pulmicort (budesonide). Common drug interactions include enterococcal sepsis among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Actigall and Pulmicort. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Actigall?

Actigall has active ingredients of ursodiol. It is often used in gallstones. eHealthMe is studying from 2,162 Actigall users. Check the latest studies of Actigall.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.



On Jul, 08, 2026

33 people who take Actigall and Pulmicort together, and have interactions are studied.

Actigall and Pulmicort drug interactions.

What are the common drug interactions of Actigall and Pulmicort, by gender? *:

female:

  1. Enterococcal sepsis
  2. Erythema (redness of the skin)
  3. Eye disorder
  4. Flushing (the warm, red condition of human skin)
  5. Gait disturbance
  6. Heart rate increased
  7. Hepatic mass
  8. Hepatocellular carcinoma (liver cancer)
  9. Hypoxia (low oxygen in tissues)
  10. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

male:

  1. Pyrexia (fever)
  2. Acidosis (build-up of carbon dioxide in the blood)
  3. Constipation
  4. Cough
  5. Cystic fibrosis (disease of the secretary glands)
  6. Diarrhoea
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Dyspnoea (difficult or laboured respiration)
  9. Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)
  10. Gastrointestinal disorder (functional problems of gastrointestinal tract)

What are the common drug interactions of Actigall and Pulmicort, by age (0-1 to 60+)? *:

0-1:

  1. Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  2. Hepatic fibrosis (scarring process that represents the liver's response to injury)
  3. Intraventricular haemorrhage neonatal (intraventricular bleeding in newborn)
  4. Lung disorder (lung disease)
  5. Necrotising colitis (inflammation in the intestines (usually the colon) that can be life-threatening)
  6. Premature baby
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Complication of pregnancy
  9. Dyspnoea (difficult or laboured respiration)
  10. Enterococcal sepsis

2-9:

  1. Catheter related infection
  2. Device failure
  3. Duodenal ulcer
  4. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  5. Volvulus of bowel (obstruction caused by twisting of bowel)

10-19:

  1. Mycobacterium abscessus infection (rapid growing bacterial infection)
  2. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  3. Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  5. Renal failure (kidney dysfunction)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Septic shock (shock due to blood infection)
  8. Staphylococcal bacteraemia (a bacterial infection of blood)
  9. Weight decreased
  10. Bilirubin conjugated increased

20-29:

  1. Dyspnoea (difficult or laboured respiration)
  2. Chest discomfort
  3. Dermatitis allergic (inflammation of the skin due allergic reaction)
  4. Pneumonia

30-39:

  1. Pyrexia (fever)
  2. Acidosis (build-up of carbon dioxide in the blood)
  3. Acute respiratory distress syndrome
  4. Anaemia (lack of blood)
  5. Asthenia (weakness)
  6. Bandaemia (excess of band cells (immature white blood cells) released by the bone marrow into the blood)
  7. Blood creatinine increased
  8. Blood urea increased
  9. Bronchial haemorrhage (bleeding in bronchia)
  10. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)

40-49:

  1. Anaemia (lack of blood)
  2. Dyspnoea (difficult or laboured respiration)
  3. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  4. Tooth extraction
  5. Uterine haemorrhage (uterine bleeding)
  6. Vaginal haemorrhage (vaginal bleeding)
  7. Acute respiratory failure

50-59:

  1. Cholangitis (infection of the bile duct)
  2. Death
  3. Fall
  4. Gait disturbance

60+:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Death
  3. Gallbladder disorder
  4. Injury
  5. Lower respiratory tract infection

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 15 people, 45.45%
  2. Pain: 13 people, 39.39%
  3. Wheezing (a high-pitched whistling sound made while you breath): 11 people, 33.33%
  4. Cough: 11 people, 33.33%
  5. Nasal Discomfort: 10 people, 30.30%
  6. Nausea (feeling of having an urge to vomit): 10 people, 30.30%
  7. High Blood Pressure: 10 people, 30.30%
  8. Rickets (softening of bones): 10 people, 30.30%
  9. Fungal Infection: 9 people, 27.27%
  10. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 9 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Actigall and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Actigall and Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actigall and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol and budesonide (the active ingredients of Actigall and Pulmicort, respectively), and Actigall and Pulmicort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: